KNSA (KNSA) Stock Price & Analysis
KNSA (KNSA) rose 0.00% to USD 62.84 as of July 25, 2026 at 03:06 UTC, according to Nexqual real-time market data.
KNSA last closed at USD 62.84; the session ranged USD 62.31–63.39 on volume of 604,888 shares. Market capitalization is —, with a 52-week range of USD 26.27–67.53 (NMS). Source: Nexqual, July 25, 2026 at 03:06 UTC.
Key Statistics (as of July 25, 2026 at 03:06 UTC)
| Price | USD 62.84 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 62.84 |
| Open | USD 62.84 |
| Day Range | USD 62.31 – 63.39 |
| 52-Week Range | USD 26.27 – 67.53 |
| Volume | 604,888 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (KNSA)
Nexqual's technical model rates KNSA "BUY" based on 4 bullish and 1 bearish signals across 125 daily candles, as of July 25, 2026 at 03:06 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 59.11 (neutral) |
| vs SMA50 | Above (USD 56.9) |
| MACD | 1.7 (positive) |
From KNSA's Latest SEC 10-K Filing (filed 2026-02-24)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| MIRM | Mirum Pharmaceuticals, Inc. | USD 113.03 | ▼ 1.27% |
| CRNX | Crinetics Pharmaceuticals, Inc. | USD 83.73 | ▲ 0.01% |
| KRYS | Krystal Biotech, Inc. | USD 335.19 | ▼ 0.48% |
| RYTM | Rhythm Pharmaceuticals, Inc. | USD 102.1 | ▼ 1.8% |
| REPL | Replimune Group, Inc. | USD 9.7 | ▼ 9.77% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 03:06 UTC. This page is informational and not investment advice.